Table 3 Summary of adverse events
Treatment emergent adverse events | UC-MSCS (N = 45) | Placebo (N = 46) |
|---|---|---|
Cerebral infarction | 1 (2.22%) | 0 |
Femoral neck fracture caused by accident | 1 (2.22%) | 0 |
Positive IAA | 0 | 1 (2.27%) |
Hyperplastic anemia | 0 | 1 (2.27%) |
Papillary thyroid carcinoma | 0 | 1 (2.27%) |
Prostate cancer | 0 | 1 (2.27%) |